Clinical Research in ALS Study
NCT00136500 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2026-03-20
Summary
CRiALS is an umbrella protocol through which people are recruited to participate in a range of research studies being conducted by the ALS Research Collaboration (ARC).
Conditions
Sponsors & Collaborators
-
ALS Association
collaborator OTHER -
ALS Recovery Fund
collaborator UNKNOWN -
University of Miami
lead OTHER
Principal Investigators
-
Michael Benatar, MD, PhD. · University of Miami
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-02-28
- Primary Completion
- 2037-12-31
- Completion
- 2037-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers
NCT01495390 ·Status: COMPLETED
-
Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS]
NCT00005674 ·Status: COMPLETED ·Phase: PHASE2
-
PREVENT ALL ALS Study
NCT06581861 ·Status: RECRUITING
-
A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT03160898 ·Status: COMPLETED ·Phase: PHASE2
-
Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT03580616 ·Status: TERMINATED ·Phase: PHASE2
-
ALS Research Collaborative
NCT06885918 ·Status: RECRUITING
-
A Study to Evaluate the Effects of Multiple Doses of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT01378676 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
NCT01730716 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of ALS Reversals 4: LifeTime Exposures
NCT03706391 ·Status: COMPLETED
-
Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis
NCT00069186 ·Status: UNKNOWN ·Phase: PHASE3
-
A Compassionate Use Protocol of AMX0035 for Treatment of Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT04516096 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Registered Cohort Study on Amyotrophic Lateral Sclerosis
NCT04008329 ·Status: RECRUITING
-
Amyotrophic Lateral Sclerosis: A Multicenter Retrospective Observational Registry
NCT07143656 ·Status: ACTIVE_NOT_RECRUITING
-
Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) Trial
NCT00035815 ·Status: COMPLETED ·Phase: PHASE3
-
Measurement and Impact of Physical Impairment in Amyotrophic Lateral Sclerosis: Use of Digital Technologies - A Precision ALS Project
NCT06820008 ·Status: RECRUITING
-
Determining the Safety of L-serine in ALS
NCT01835782 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Intramuscular Infusion of Autologous Bone Marrow Stem Cells in Patients With Amyotrophic Lateral Sclerosis
NCT02286011 ·Status: UNKNOWN ·Phase: PHASE1
-
TRIAL READY (Clinical Trial Readiness)
NCT03912987 ·Status: ACTIVE_NOT_RECRUITING
-
A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension, to Evaluate Safety, Tolerability and Efficacy of PrimeC in Subjects With ALS
NCT05357950 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis
NCT01492686 ·Status: COMPLETED ·Phase: PHASE3
-
Study of ALS Reversals 2: Genetic Analyses
NCT03464903 ·Status: COMPLETED
-
A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALS
NCT05053035 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation
NCT02794857 ·Status: COMPLETED ·Phase: PHASE2
-
Neurofilament Light Chain in Amyotrophic Lateral Sclerosis
NCT06201650 ·Status: RECRUITING
-
Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis
NCT00706147 ·Status: COMPLETED ·Phase: PHASE2/PHASE3